772 related articles for article (PubMed ID: 20618508)
1. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Ding WY; Lee CK; Choon SE
Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
[TBL] [Abstract][Full Text] [Related]
2. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.
Sharma VK; Sethuraman G; Kumar B
J Postgrad Med; 2001; 47(2):95-9. PubMed ID: 11832597
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
Chattopadhyay C; Chakrabarti N
Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
[TBL] [Abstract][Full Text] [Related]
5. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
Tan SK; Tay YK
Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital.
Sushma M; Noel MV; Ritika MC; James J; Guido S
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):567-70. PubMed ID: 15937869
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China.
Li LF; Ma C
Clin Exp Dermatol; 2006 Sep; 31(5):642-7. PubMed ID: 16901302
[TBL] [Abstract][Full Text] [Related]
8. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
Kim HK; Kim DY; Bae EK; Kim DW
J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of cutaneous adverse drug reactions.
Mockenhaupt M
Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
[TBL] [Abstract][Full Text] [Related]
10. A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia.
Loo CH; Tan WC; Khor YH; Chan LC
Med J Malaysia; 2018 Apr; 73(2):73-77. PubMed ID: 29703869
[TBL] [Abstract][Full Text] [Related]
11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H
Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
14. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
15. Severe adverse cutaneous drug eruptions: epidemiological and clinical features.
Zaraa I; Jones M; Trojjet S; Cheikh Rouhou R; El Euch D; Mokni M; Ben Osman A
Int J Dermatol; 2011 Jul; 50(7):877-80. PubMed ID: 21699528
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous adverse drug reactions in children. A series of 90 cases.
Khaled A; Kharfi M; Ben Hamida M; El Fekih N; El Aidli S; Zeglaoui F; Ezzine N; Fazaa B; Kamoun MR
Tunis Med; 2012 Jan; 90(1):45-50. PubMed ID: 22311448
[TBL] [Abstract][Full Text] [Related]
18. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Kasemsarn P; Kulthanan K; Tuchinda P; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2011 Oct; 10(10):1160-7. PubMed ID: 21968666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
